Luara Isabela dos Santos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Luara Isabela dos Santos has a total of 94 co-authors. Here are the top co-authors by number of shared publications:
- Ricardo Tostes Gazzinelli
Centro de Tecnologia de Vacinas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
5 shared publications - Alexandre Vieira Machado
René Rachou Research Center, Fiocruz, Minas Gerais, Brazil
2 shared publications Bruno Galvão-Filho
Fundação Oswaldo Cruz
2 shared publications- Camile Rabello Netto Gribel2 shared publications
Caroline Junqueira
Fundação Oswaldo Cruz
2 shared publications- Dawidson Assis Gomes
Multibiq, Laboratory of Multi-Users Equipments, Department of Biochemestry and Imunology, Federal University of Minas Gerais, Belo Horizonte 31270-901, Brazil
2 shared publications
Latest Publications
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 71 (12) , e20250360
Immunoglobulin G and neutralizing antibody response after CoronaVac
SUMMARY OBJECTIVE: The aim of this study was to evaluate the kinetics of immunoglobulin G and neutralizing antibody responses following vaccination with CoronaVac in healthcare professionals. METHODS: A cohort of 35 healthcare professionals was recruited, and blood samples were collected to assess immunoglobulin G detection and neutralizing antibodies against severe acute respiratory syndrome coronavirus 2. RESULTS: Immunoglobulin G seroconversion peaked at D30 (68.2%, 15/22), followed by stabilization at D48 and D90. Logistic regression confirmed a significant association between time post-vaccination and seroconversion (p=0.0043). Neutralizing antibody analysis showed a stable detection rate for Nab V1 (Wuhan and B.1.1.7) between D48 and D90 (p>0.9999), while Nab V2 (B.1.351 and P.1) remained consistently lower. Among immunoglobulin G-positive individuals, 92.3% (12/13) had neutralizing antibodies at D48, decreasing to 42.8% (6/14) at D90. CONCLUSION: CoronaVac effectively induces immunoglobulin G seroconversion, peaking at D30. However, neutralizing responses to emerging variants were lower, suggesting the need for booster doses to maintain immunity. These findings highlight the importance of monitoring vaccine-induced immunity over time.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 71 (12) , e20250360
Open AccessImmunoglobulin G and neutralizing antibody response after CoronaVac
SUMMARY OBJECTIVE: The aim of this study was to evaluate the kinetics of immunoglobulin G and neutralizing antibody responses following vaccination with CoronaVac in healthcare professionals. METHODS: A cohort of 35 healthcare professionals was recruited, and blood samples were collected to assess immunoglobulin G detection and neutralizing antibodies against severe acute respiratory syndrome coronavirus 2. RESULTS: Immunoglobulin G seroconversion peaked at D30 (68.2%, 15/22), followed by stabilization at D48 and D90. Logistic regression confirmed a significant association between time post-vaccination and seroconversion (p=0.0043). Neutralizing antibody analysis showed a stable detection rate for Nab V1 (Wuhan and B.1.1.7) between D48 and D90 (p>0.9999), while Nab V2 (B.1.351 and P.1) remained consistently lower. Among immunoglobulin G-positive individuals, 92.3% (12/13) had neutralizing antibodies at D48, decreasing to 42.8% (6/14) at D90. CONCLUSION: CoronaVac effectively induces immunoglobulin G seroconversion, peaking at D30. However, neutralizing responses to emerging variants were lower, suggesting the need for booster doses to maintain immunity. These findings highlight the importance of monitoring vaccine-induced immunity over time.
- Open Access
- 22 December 2024
- Published by Elsevier in Public Health in Practice
- Vol. 9, 100567
Assessing the impact of HIV self-testing on diagnosis rates in vulnerable groups in belo horizonte, Brazil: A cross-sectional analysis
- 22 December 2024
- Published by Elsevier in Public Health in Practice
- Vol. 9, 100567
Open AccessAssessing the impact of HIV self-testing on diagnosis rates in vulnerable groups in belo horizonte, Brazil: A cross-sectional analysis
- 3 September 2024
- Published by Elsevier in Transplant Immunology
- Vol. 86, 102116
Impact of donor expanded criteria kidney transplantation on clinical outcomes and survival: A single-center experience
- 3 September 2024
- Published by Elsevier in Transplant Immunology
- Vol. 86, 102116
Impact of donor expanded criteria kidney transplantation on clinical outcomes and survival: A single-center experience
- Open Access
- 1 January 2024
- Published by GN1 Sistemas e Publicacoes Ltd. in REVISTA MÉDICA DE MINAS GERAIS
- Vol. 34 (1) , 1-8
SARS-CoV-2 em pediatria: uma análise dos pacientes internados com suspeita de COVID-19 em um hospital do interior de Minas Gerais
- 1 January 2024
- Published by GN1 Sistemas e Publicacoes Ltd. in REVISTA MÉDICA DE MINAS GERAIS
- Vol. 34 (1) , 1-8
Open AccessSARS-CoV-2 em pediatria: uma análise dos pacientes internados com suspeita de COVID-19 em um hospital do interior de Minas Gerais
- Open Access
- 1 January 2024
- Published by GN1 Sistemas e Publicacoes Ltd. in REVISTA MÉDICA DE MINAS GERAIS
- Vol. 34 (1) , 1-8
SARS-CoV-2 in pediatrics: an analysis of hospitalized patients with suspected COVID-19 in a hospital in the interior of Minas Gerais
- 1 January 2024
- Published by GN1 Sistemas e Publicacoes Ltd. in REVISTA MÉDICA DE MINAS GERAIS
- Vol. 34 (1) , 1-8
Open AccessSARS-CoV-2 in pediatrics: an analysis of hospitalized patients with suspected COVID-19 in a hospital in the interior of Minas Gerais
- Open Access
- 1 December 2023
- Published by MDPI AG in Medical Sciences Forum
- Vol. 26 (1) , 4
Impact of COVID-19 on Influenza Virus Vaccination Coverage
Influenza vaccination is pivotal in alleviating healthcare burdens and possibly curbing COVID-19 infections due to symptom overlap. Despite previous suboptimal vaccination rates, the exceptional circumstances of the pandemic may have impacted influenza vaccine coverage in 2020 and 2021. This quantitative analytical study of a cross-sectional nature examines influenza vaccination adherence from 2019 to 2021 at a private vaccination clinic in Belo Horizonte, Brazil, while considering demographic variables. Socioeducational measures and government vaccination incentives seem to have played a significant role in this increase. Nonetheless, the substantial surge observed between 2019 and 2020 is likely linked to the population’s heightened COVID-19-related apprehensions.
- 1 December 2023
- Published by MDPI AG in Medical Sciences Forum
- Vol. 26 (1) , 4
Open AccessImpact of COVID-19 on Influenza Virus Vaccination Coverage
Influenza vaccination is pivotal in alleviating healthcare burdens and possibly curbing COVID-19 infections due to symptom overlap. Despite previous suboptimal vaccination rates, the exceptional circumstances of the pandemic may have impacted influenza vaccine coverage in 2020 and 2021. This quantitative analytical study of a cross-sectional nature examines influenza vaccination adherence from 2019 to 2021 at a private vaccination clinic in Belo Horizonte, Brazil, while considering demographic variables. Socioeducational measures and government vaccination incentives seem to have played a significant role in this increase. Nonetheless, the substantial surge observed between 2019 and 2020 is likely linked to the population’s heightened COVID-19-related apprehensions.
- 7 July 2023
- Published by Elsevier in Preventive Medicine
- Vol. 173, 107602
Impacts of the COVID-19 pandemic on immunization with pneumococcal vaccines in children and older adults in Brazil
- 7 July 2023
- Published by Elsevier in Preventive Medicine
- Vol. 173, 107602
Impacts of the COVID-19 pandemic on immunization with pneumococcal vaccines in children and older adults in Brazil
- 13 September 2019
- Published by Wiley in Artificial Organs
- Vol. 44 (3) , 296-304
Effect of the expression of CD62P and thrombin generation on patients using central venous catheters for hemodialysis
The formation of thrombi in medical devices that come into contact with blood is a common cause of increased morbidity and mortality. Prolonged use of central venous catheters (CVCs) may cause high infection rates or compromise CVC patency due to thrombus development. In this study, we sought insights into possible changes in the hemostatic system during prolonged use of inserted CVCs for hemodialysis by assessing platelets by CD62P and CD41a expression and the potential for thrombin generation (TG). This study included patients with chronic renal failure who were undergoing hemodialysis three times a week using a CVC, and healthy subjects as controls. The participants were distributed into three groups: Group 1: clinically and laboratorially healthy individuals matched by sex and age to the patients (controls); Group II: patients who had completed 1 month of CVC insertion; and Group III: the same patients after they had completed 4 months of CVC insertion. Platelet activation analysis and TG evaluation were performed using blood samples obtained through two different accesses, that is, through a peripheral vein and directly from the CVC lumen. The data showed platelet activation and an increase in the generation of thrombin, particularly after 4 months of CVC use. The results also indicated that insertion of the catheter into the blood stream stimulated the intrinsic rather than the extrinsic pathway. Taken together, the data showed a direct relationship between the use of CVCs in hemodialysis patients and a state of hypercoagulability, most likely associated with endothelial damage and the contact of the medical device with blood components such as platelets and coagulation factors.
- 13 September 2019
- Published by Wiley in Artificial Organs
- Vol. 44 (3) , 296-304
Effect of the expression of CD62P and thrombin generation on patients using central venous catheters for hemodialysis
The formation of thrombi in medical devices that come into contact with blood is a common cause of increased morbidity and mortality. Prolonged use of central venous catheters (CVCs) may cause high infection rates or compromise CVC patency due to thrombus development. In this study, we sought insights into possible changes in the hemostatic system during prolonged use of inserted CVCs for hemodialysis by assessing platelets by CD62P and CD41a expression and the potential for thrombin generation (TG). This study included patients with chronic renal failure who were undergoing hemodialysis three times a week using a CVC, and healthy subjects as controls. The participants were distributed into three groups: Group 1: clinically and laboratorially healthy individuals matched by sex and age to the patients (controls); Group II: patients who had completed 1 month of CVC insertion; and Group III: the same patients after they had completed 4 months of CVC insertion. Platelet activation analysis and TG evaluation were performed using blood samples obtained through two different accesses, that is, through a peripheral vein and directly from the CVC lumen. The data showed platelet activation and an increase in the generation of thrombin, particularly after 4 months of CVC use. The results also indicated that insertion of the catheter into the blood stream stimulated the intrinsic rather than the extrinsic pathway. Taken together, the data showed a direct relationship between the use of CVCs in hemodialysis patients and a state of hypercoagulability, most likely associated with endothelial damage and the contact of the medical device with blood components such as platelets and coagulation factors.
- 14 May 2019
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 106 (3) , 641-652
Increased frequencies of circulating CCR5+ memory T cells are correlated to chronic chagasic cardiomyopathy progression
The infection with the protozoan parasite Trypanosoma cruzi causes Chagas disease, a neglected tropical disease in Latin America and an imported emerging disease worldwide. Chronic Chagasic cardiomyopathy (CCC), a progressive inflammatory and fibrosing disease, is the most prominent clinical form of Chagas disease, culminating in heart failure and high rates of sudden death. CCC pathogenesis is influenced by both host and parasite factors and is proposed to be mostly immune‐driven. Chemokines are crucial players in orchestrating immune cell recruitment to infected tissues and inflammation. Herein, we investigated inflammatory chemokine receptor expression on circulating T cells in patients stratified by CCC severity. Compared to asymptomatic individuals, we found increased percentages of effector CD4+ T cells and central memory CD4+ and CD8+ T cells expressing CCR5 in patients with structural cardiopathy, but normal global ventricular function and no symptoms of chronic heart failure. Even naïve T cells expressed CCR5 in these patients. In contrast, reduced frequencies of CD4+ and CD8+ effector T cells expressing CXCR3 were observed in patients presenting with severe heart disease. Patients with increased left ventricular diameter, heart enlargement, and insufficiency had higher frequencies of CCR5+ effector and effector memory CD8+ T cells. Moreover, the percentage of effector CCR5+ CD8+ T cells was increased in patients with a reduced ejection fraction. Our results show that high expression CCR5 and low expression of CXCR3 on circulating T cells are associated with worse prognosis, possibly reflecting immune‐mediated cardiac remodeling of CCC.
- 14 May 2019
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 106 (3) , 641-652
Increased frequencies of circulating CCR5+ memory T cells are correlated to chronic chagasic cardiomyopathy progression
The infection with the protozoan parasite Trypanosoma cruzi causes Chagas disease, a neglected tropical disease in Latin America and an imported emerging disease worldwide. Chronic Chagasic cardiomyopathy (CCC), a progressive inflammatory and fibrosing disease, is the most prominent clinical form of Chagas disease, culminating in heart failure and high rates of sudden death. CCC pathogenesis is influenced by both host and parasite factors and is proposed to be mostly immune‐driven. Chemokines are crucial players in orchestrating immune cell recruitment to infected tissues and inflammation. Herein, we investigated inflammatory chemokine receptor expression on circulating T cells in patients stratified by CCC severity. Compared to asymptomatic individuals, we found increased percentages of effector CD4+ T cells and central memory CD4+ and CD8+ T cells expressing CCR5 in patients with structural cardiopathy, but normal global ventricular function and no symptoms of chronic heart failure. Even naïve T cells expressed CCR5 in these patients. In contrast, reduced frequencies of CD4+ and CD8+ effector T cells expressing CXCR3 were observed in patients presenting with severe heart disease. Patients with increased left ventricular diameter, heart enlargement, and insufficiency had higher frequencies of CCR5+ effector and effector memory CD8+ T cells. Moreover, the percentage of effector CCR5+ CD8+ T cells was increased in patients with a reduced ejection fraction. Our results show that high expression CCR5 and low expression of CXCR3 on circulating T cells are associated with worse prognosis, possibly reflecting immune‐mediated cardiac remodeling of CCC.
- 1 March 2019
- Published by Elsevier in Clinica Chimica Acta
- Vol. 490, 107-112
Correlation between active disease and hypercoagulability state in patients with systemic lupus erythematosus
- 1 March 2019
- Published by Elsevier in Clinica Chimica Acta
- Vol. 490, 107-112
Correlation between active disease and hypercoagulability state in patients with systemic lupus erythematosus